Biotech Values

[Tamhas]

I get that it would have been a whole lot nicer if the Bydureon results were equal or better than Victoza, but we are also comparing a once a week to a once a day medication regime, which still seems like a big appeal to the user. Given a choice between once a day and once a week at an average of 87% effectiveness, it seems like there are a lot of people, particularly those who don't have as big of a control problem, would still find this an attractive choice.